IMS Solutions Overview

  • Year Founded
  • 2025

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $1.48M

  • Investors
  • 9

IMS Solutions General Information

Description

Developer of a diagnostic platform intended to identify conditions featuring disordered steroid metabolism. The company utilizes mass spectrometry and machine learning algorithms to detect unique steroid signatures in urine and blood, providing adrenal cancer diagnostics, steroid profiling technology, hormone stratification tests, diagnostic reporting software, urine analysis kits, and blood biomarker panels, enabling healthcare providers to accurately distinguish between malignant and benign tumors and improve patient management.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 5 Wellington Grove
  • Solihull B91 1EA
  • England, United Kingdom
Primary Industry
Decision/Risk Analysis
Other Industries
Laboratory Services (Healthcare)
Diagnostic Equipment
Corporate Office
  • 5 Wellington Grove
  • Solihull B91 1EA
  • England, United Kingdom

IMS Solutions Timeline

2026
Date FoundedFinancing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

IMS Solutions Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Seed Round 24-Sep-2026 $1.48M Completed Startup
3. Grant 24-Sep-2026 Completed Startup
2. Accelerator/Incubator Completed Startup
1. University Spin-Out 09-Apr-2025 Completed Startup
To view IMS Solutions’s complete valuation and funding history, request access »

IMS Solutions Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
British Business Bank Lender/Debt Provider Minority
Future Planet Capital Venture Capital Minority
Midlands Mindforge Impact Investing Minority
National Institute for Health and Care Research Government
NG Bio (UK) Venture Capital Minority
You’re viewing 5 of 9 investors. Get the full list »

IMS Solutions FAQs

  • When was IMS Solutions founded?

    IMS Solutions was founded in 2025.

  • Where is IMS Solutions headquartered?

    IMS Solutions is headquartered in Solihull, United Kingdom.

  • What industry is IMS Solutions in?

    IMS Solutions’s primary industry is Decision/Risk Analysis.

  • Is IMS Solutions a private or public company?

    IMS Solutions is a Private company.

  • What is IMS Solutions’s current revenue?

    The current revenue for IMS Solutions is .

  • How much funding has IMS Solutions raised over time?

    IMS Solutions has raised $1.48M.

  • Who are IMS Solutions’s investors?

    British Business Bank, Future Planet Capital, Midlands Mindforge, National Institute for Health and Care Research, and NG Bio (UK) are 5 of 9 investors who have invested in IMS Solutions.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process